歡迎光臨源葉生物,登錄 | 注冊 |
當前位置: 首頁 > 小分子抑制劑 > Metabolism > BVT 2733

瀏覽歷史

S85168

BVT 2733

源葉(MedMol) 95%
  • 英文名:
  • BVT 2733
  • 別名:
  • CAS號:
  • 376640-41-4
  • 分子式:
  • C17H21ClN4O3S2
  • 分子量:
  • 428.9566
  • 核磁/質(zhì)譜:
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S85168-2mg 95% ¥160.00元 5 - - - EA 加入購物車
源葉(MedMol) S85168-5mg 95% ¥300.00元 6 - - - EA 加入購物車
源葉(MedMol) S85168-10mg 95% ¥520.00元 6 - - - EA 加入購物車
源葉(MedMol) S85168-25mg 95% ¥1070.00元 6 - - - EA 加入購物車
源葉(MedMol) S85168-50mg 95% ¥1770.00元 5 - - - EA 加入購物車
源葉(MedMol) S85168-100mg 95% ¥2560.00元 預(yù)計交期:2-3天 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權(quán)與保護申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻

質(zhì)檢證書(COA)

摩爾濃度計算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: BVT 2733 is a potent, selective, and orally active non-steroidal 11β-hydroxydehydrogenase 1 (11β-HSD1) inhibitor. BVT 2733 is potently against the mouse enzyme (IC50=96 nM) over the human enzyme (IC50=3341 nM). BVT 2733 has the potential for the study of arthritis and obesity related disease
  • 靶點: IC50: 96 nM (mouse 11β-HSD1) IC50: 3341 nM (human 11β-HSD1);Dehydrogenase
  • 體外研究:
    BVT 2733 (100 μM; 24 hours) co-treatment with PA (100 μM) reduces MCP-1 expression in fully differentiation adipocytes. BVT 2733 (50-100 μM; 24 hours) reduces the inflammation protein levels (MCP-1, IL-6) in medium in J774.1 macrophages by Elisa. RT-PCR Cell Line: Differentiation adipocytes Concentration: 100 μM Incubation Time: 24 hours Result: Down-regulated MCP-1 mRNA level.
  • 體內(nèi)研究:
    BVT-2733 (oral administration; 100 mg/kg; twice daily; 2 weeks) attenuates the arthritis severity and anti-CII level and decreases the levels of serum TNF-α, IL-1β, IL-6 and IL-17 in CIA mice. BVT 2733 (oral administration; 100 mg/kg; dosed (09.00 and 17.00 h); last 4 weeks) exhibits decreased body weight and enhanced glucose tolerance and insulin sensitivity when it compares to control mice. It also down-regulated the expression of inflammation-related genes including monocyte chemoattractant protein 1 (MCP-1), tumor necrosis factor alpha (TNF-α) and the number of infiltrated macrophages within the adipose tissue in vivo. Animal Model: Collagen-induced arthritis (CIA) mice Dosage: 100 mg/kg Administration: Oral administration; twice daily; 2 weeks Result: Reduced synovial inflammation and joint destruction. Animal Model: C57BL/6J mice Dosage: 100 mg/kg Administration: Oral administration; dosed (09.00 and 17.00 h); last 4 weeks Result: Improved metabolic homeostasis and suppressed the inflammation of adipose tissue in diet-induced obese mice.
  • 參考文獻:
    1. 11β-hydroxydehydrogenase 1 (11β-HSD1) Inhibitor in Development 2. Zhang L, et al. 11β-Hydroxysteroid dehydrogenase 1 inhibition attenuates collagen-induced arthritis. Int Immunopharmacol. 2013 Nov;17(3):489-94. 3. Wang L, et al. BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice. PLoS One. 2012;7(7):e40056.
  • 溶解性: Soluble  in  DMSO
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.331 ml 11.656 ml 23.312 ml
    5 mM 0.466 ml 2.331 ml 4.662 ml
    10 mM 0.233 ml 1.166 ml 2.331 ml
    50 mM 0.047 ml 0.233 ml 0.466 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: BVT 2733 is a potent, selective, and orally active non-steroidal 11β-hydroxydehydrogenase 1 (11β-HSD1) inhibitor. BVT 2733 is potently against the mouse enzyme (IC50=96 nM) over the human enzyme (IC50=3341 nM). BVT 2733 has the potential for the study of arthritis and obesity related disease
  • 靶點: IC50: 96 nM (mouse 11β-HSD1) IC50: 3341 nM (human 11β-HSD1);Dehydrogenase
  • 體外研究:
    BVT 2733 (100 μM; 24 hours) co-treatment with PA (100 μM) reduces MCP-1 expression in fully differentiation adipocytes. BVT 2733 (50-100 μM; 24 hours) reduces the inflammation protein levels (MCP-1, IL-6) in medium in J774.1 macrophages by Elisa. RT-PCR Cell Line: Differentiation adipocytes Concentration: 100 μM Incubation Time: 24 hours Result: Down-regulated MCP-1 mRNA level.
  • 體內(nèi)研究:
    BVT-2733 (oral administration; 100 mg/kg; twice daily; 2 weeks) attenuates the arthritis severity and anti-CII level and decreases the levels of serum TNF-α, IL-1β, IL-6 and IL-17 in CIA mice. BVT 2733 (oral administration; 100 mg/kg; dosed (09.00 and 17.00 h); last 4 weeks) exhibits decreased body weight and enhanced glucose tolerance and insulin sensitivity when it compares to control mice. It also down-regulated the expression of inflammation-related genes including monocyte chemoattractant protein 1 (MCP-1), tumor necrosis factor alpha (TNF-α) and the number of infiltrated macrophages within the adipose tissue in vivo. Animal Model: Collagen-induced arthritis (CIA) mice Dosage: 100 mg/kg Administration: Oral administration; twice daily; 2 weeks Result: Reduced synovial inflammation and joint destruction. Animal Model: C57BL/6J mice Dosage: 100 mg/kg Administration: Oral administration; dosed (09.00 and 17.00 h); last 4 weeks Result: Improved metabolic homeostasis and suppressed the inflammation of adipose tissue in diet-induced obese mice.
  • 參考文獻:
    1. 11β-hydroxydehydrogenase 1 (11β-HSD1) Inhibitor in Development 2. Zhang L, et al. 11β-Hydroxysteroid dehydrogenase 1 inhibition attenuates collagen-induced arthritis. Int Immunopharmacol. 2013 Nov;17(3):489-94. 3. Wang L, et al. BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice. PLoS One. 2012;7(7):e40056.
  • 溶解性: Soluble  in  DMSO
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.331 ml 11.656 ml 23.312 ml
    5 mM 0.466 ml 2.331 ml 4.662 ml
    10 mM 0.233 ml 1.166 ml 2.331 ml
    50 mM 0.047 ml 0.233 ml 0.466 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。
点击收缩